We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Sustained humoral response 6 months after the anti-SARS-CoV-2 mRNA-BNT162b2 vaccine in haemodialysis patients: should booster vaccine doses be given to all patients at the same time?
- Authors
Milia, Vincenzo La; Tonolo, Silvia; Luzzaro, Francesco; Bonato, Claudio; Limardo, Monica; Longhi, Selena; Ravasi, Chiara; Viganò, Sara; Cavalli, Andrea
- Abstract
In haemodialysis (HD) patients persistent seroconversion (PSC) was found 6 months after natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection [[1]] and in 71-98% of patients after complete vaccination [[2]]. (A) All patients (r2 = 0.01); (B) patients without seroconversion 6 months after the second dose vaccine administration (r2 = 0.25); (C) patients with seroconversion 6 months after the second dose vaccine administration (r2 = 0.09); (D) patients with seroconversion 6 months after the second dose vaccine administration and IgG anti-SARS-CoV-2 positive at administration of first vaccine dose (r2 = 0.004).
- Subjects
BOOSTER vaccines; HEMODIALYSIS patients; HUMORAL immunity; SARS-CoV-2
- Publication
Clinical Kidney Journal, 2022, Vol 15, Issue 5, p1012
- ISSN
2048-8505
- Publication type
Article
- DOI
10.1093/ckj/sfac047